Top Markets
#1 Islamic Coin Islamic Coin +152.27%
#2 Bitway Bitway +49.98%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +38.40%
#4 Starpower Starpower +33.78%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.43%
#6 Pons Pons +21.35%
#7 Decred Decred +20.90%
#8 aelf aelf +19.43%
#9 Pleasing Gold Pleasing Gold +17.80%
#10 Venom Venom +15.71%
Coin of the day
Islamic Coin Islamic Coin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Perseus Proteomics Inc. Perseus Proteomics Inc.

Perseus Proteomics Inc.

4882
Rangering i aksjer #30410
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology... Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.
Aksjekurs
$0.91993619
Markedsverdi
$16.95M
Endring (1 dag)
-2.76%
Endring (1 år)
-63.00%
Land
JP
Handel Perseus Proteomics Inc. (4882)

Kategori

Healthcare
Inntekter for Perseus Proteomics Inc. (4882)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Perseus Proteomics Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Perseus Proteomics Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B -
US